FOYA Program

InTouch

Introducing the 2024 ISPE FOYA Submission Finalists

1 July 2024

Each year, ISPE recognizes innovation in pharmaceutical facilities with the Facility of the Year Awards (FOYA). The 2024 FOYA submission finalists were announced at the 2024 ISPE Aseptic Conference in Vienna, Austria. Finalists for the 2024 awards highlight the continued progress and innovation at play in pharmaceutical manufacturing worldwide and across modalities. From projects tailored to...

iSpeak Blog

Innovation in Action: Eli Lilly's Award-Winning Synthetic Peptide Manufacturing Facility

4 June 2024

Eli Lilly has recently achieved a remarkable milestone with the completion of its new synthetic peptide manufacturing facility/platform at its facility in Kinsale, Ireland. This cutting-edge project not only enhances production capabilities but also exemplifies a commitment to innovation and safety. Below is an overview which delves into the details of this groundbreaking achievement and...

Media & Press Releases

Facilities of the Future: Meeting the Demands of Breakthrough Therapeutics

10 May 2024

Pharmaceutical manufacturing facilities need to evolve to satisfy growing demands, as breakthrough therapeutics approach commercialization. The pharmaceutical industry can enhance efficiency, flexibility, and product quality, by systematically...

Media & Press Releases

The Facility of the Year Awards

18 April 2024

Judges Name Four Category Winners Plus Two Honorable Mentions with Plans to Unveil Overall FOYA Winner at the 2024 ISPE Annual Meeting & Expo, 13 October, in Orlando, Florida, USA ISPE recently announced category winners for its 2024 Facility of the...

2024 ISPE FOYA Category Winner for Innovation

FOYA

Eli Lilly Kinsale Limited Location: Kinsale, Ireland Project: IE2b Eli Lilly recently completed a new synthetic peptide manufacturing platform/facility in its existing Kinsale, Ireland facility. The project was completed...

2024 ISPE FOYA Category Winner for Operations – Facility Fit

FOYA

Takeda Austria GmbH Location: Linz, Austria Project: beePFS - Prefilled Syringe Filling Takeda is a global values-based, R&D-driven biopharmaceutical leader committed to creating better health for people and a brighter...

Media & Press Releases

ISPE Announces 2024 Facility of the Year Awards Submission Finalists 

19 March 2024

The 2024 Facility of the Year Awards (FOYA) submission finalists are announced at the 2024 ISPE Aseptic Conference, taking place in Vienna, Austria, and virtually.  ISPE is pleased to announce the 2024 Facility of the Year Awards (FOYA) submission...

Media & Press Releases

The Trends That Will Shape the Biotech Industry in 2024

02 February 2024

ISPE President and CEO Thomas Hartman provides insights on how AI may impact the biotech industry in 2024. Thomas observes that the meteoric rise of AI took every industry by surprise in 2023. In 2024, he notes, “companies will have more time to take...

Media & Press Releases

Scrip Asks…What Does 2024 Hold for Biopharma?

01 February 2024

ISPE President and CEO Thomas Hartman calls attention to the importance of addressing drug shortages in 2024 in part three of an article, “Scrip Asks…What Does 2024 Hold for Biopharma?” The article features expert insights on manufacturing and supply...

Media & Press Releases

Thomas Hartman - President & CEO ISPE

12 January 2024

Thomas Hartman, President and CEO of ISPE, has been featured in a recent podcast episode with Life Science Success. He and the host, Don Davis, discuss Hartman’s career journey and the impact ISPE is having on the industry. Hartman touches on...